Halozyme Therapeutics, Inc. (HALO)

69.29 +2.65 (+3.98%) USD  |  NASDAQ  |  Apr 17, 16:00
69.08 -0.21 (-0.30%) Pre-Market: 09:25
More

Halozyme Therapeutics Price Target Upside (Daily)

Price Target Upside (Daily) Chart

View Price Target Upside (Daily) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Upside (Daily) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Upside (Daily) Range, Past 5 Years

View Price Target Upside (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Upside (Daily) Benchmarks

View Price Target Upside (Daily) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Baxter International, Inc. Upgrade
Glaukos Corp. Upgrade